Patrizio Armeni

Government, Health and Not for Profit

Biography

Latest publications

ROGNONI C., Lorusso D., COSTA F., ARMENI P. Cost-Effectiveness Analysis of HRD Testing for Previously Treated Patients with Advanced Ovarian Cancer in Italy Advances in Therapy, 2024, vol.41, no. 4, pp.1385-1400
Arsenault C., Lewis T. P., Kapoor N. R., Okiro E. A., Leslie H. H., ARMENI P., Jarhyan P., Doubova S. V., Wright K. D., Aryal A., Kounnavong S., Mohan S., Odipo E., Lee H., Shin J., Ayele W., Medina-Ranilla J., Espinoza-Pajuelo L., Derseh Mebratie A., García Elorrio E., Mazzoni A., Oh J., SteelFisher G. K., TARRICONE R., Kruk M. E. Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries The Lancet Global Health, 2024, vol.12, no. 1, pp.e156-e165
ARMENI P., CALLEA G., COSTA F., MALANDRINI F., OTTO M., SEGANTIN G., SIRENA P., TARRICONE R. Il payback come misura di contenimento della spesa per farmaci e dispositivi medici in Rapporto OASI 2023 CERGAS (Eds),Egea, chap. 17, pp.651-698, 2023
ARMENI P., COSTA F., JOMMI C., MALANDRINI F., OTTO M., TARANTOLA A. L’evoluzione del finanziamento dei farmaci in Italia in Rapporto OASI 2023 CERGAS (Eds),Egea, chap. 8, pp.317-354, 2023
ARMENI P., MEREGAGLIA M., BORSOI L., CALLEA G., TORBICA A., Benazzo F., TARRICONE R. Collecting Physicians’ Preferences on Medical Devices: Are We Doing It Right? Evidence from Italian Orthopedists Using 2 Different Stated Preference Methods Medical Decision Making, 2023, vol.43, no. 7-8, pp.886-900
JOMMI C., BERTOLANI A., ARMENI P., COSTA F., OTTO M. Pharmaceutical pricing and managed entry agreements: an exploratory study on future perspectives in Europe Health Policy and Technology, 2023, vol.12, no. 2, pp.100771

Grants & Honors

ViviSalute Award - ViviSalute Lombardia , 2016
Best Paper in Healthcare Management - AIES - Italian Health Economics Association , 2015
Best Paper by Young Researchers - AIES - Italian Health Economics Association , 2010

Related Articles

La salute e la Sanità al tempo dell’AI
Authors
Required time 20 min
mHealth in oncology: limits and potential
Required time 6 min

Director

Market access dei farmaci a 360°
  • Start date
  • Duration
  • Format
  • Language
  • 10 Jun 2024
  • 4 days
  • Class
  • Italian

Approfondire il contesto in cui operano gli attori del sistema salute, le principali tecniche per veicolare il valore di un farmaco e per una negoziazione sostenibile.